The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty
Official Title: Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty: Retrospective Observational Study
Study ID: NCT06244498
Brief Summary: This study assesses the safety and efficacy of TXA for patients treated for pathological femur fractures using modular prosthetics.
Detailed Description: Tranexamic acid is an efficacious medication for curtailing blood loss, haemoglobin drop, and the requirement for transfusions. Additionally, it is a secure medication, even when administered to oncology patients receiving reduction haemarthroplasty for pathological femoral fractures.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
SzSPOO Brzozów, Brzozów, Podkarpackie, Poland